Anya Biopharm Inc. (TPEX:7776)
Taiwan · Delayed Price · Currency is TWD 29.40
-3.10 (-9.54%)
At close: Jul 29, 2026
Anya Biopharm Market Cap
Anya Biopharm has a market cap or net worth of 1.48 billion as of July 29, 2026. Its market cap has decreased by -23.64% in one year.
Market Cap
1.48B
Enterprise Value
1.12B
Revenue
16.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
29.40
ChartMarket Cap Chart
Since October 25, 2024, Anya Biopharm's market cap has decreased from 2.85B to 1.48B, a decrease of -48.02%. That is a compound annual growth rate of -31.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 1.60B | -32.01% |
| Dec 31, 2025 | 2.35B | 26.96% |
| Dec 31, 2024 | 1.85B | -35.20% |
| Oct 25, 2024 | 2.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 8.08B |
| Taho Pharmaceuticals | 5.55B |
| TEH SENG Pharmaceutical Mfg. | 2.58B |
| Libo Pharma | 2.21B |
| Anbogen Therapeutics | 1.74B |
| Timing Pharmaceutial | 1.69B |
| TSA International | 1.58B |
| Gin Hwa Biotech Incorporation | 1.50B |